These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
800 related items for PubMed ID: 25828755
1. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis. Kohlmann R, Salmen A, Chan A, Knabbe C, Diekmann J, Brockmeyer N, Skaletz-Rorowski A, Michalik C, Gold R, Überla K. Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755 [Abstract] [Full Text] [Related]
2. Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity. Rondaan C, van Leer CC, van Assen S, Bootsma H, de Leeuw K, Arends S, Bos NA, Westra J. Lupus; 2018 Jul; 27(8):1271-1278. PubMed ID: 29667858 [Abstract] [Full Text] [Related]
3. Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation. Yamazaki R, Nakasone H, Tanaka Y, Sato M, Terasako K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. Biol Blood Marrow Transplant; 2013 Jul; 19(7):1013-20. PubMed ID: 23583826 [Abstract] [Full Text] [Related]
4. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation. Ogunjimi B, Theeten H, Hens N, Beutels P. J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981 [Abstract] [Full Text] [Related]
5. T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Ricklin ME, Lorscheider J, Waschbisch A, Paroz C, Mehta SK, Pierson DL, Kuhle J, Fischer-Barnicol B, Sprenger T, Lindberg RL, Kappos L, Derfuss T. Neurology; 2013 Jul 09; 81(2):174-81. PubMed ID: 23700335 [Abstract] [Full Text] [Related]
6. Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients. Onozawa M, Hashino S, Takahata M, Fujisawa F, Kawamura T, Nakagawa M, Kahata K, Kondo T, Ota S, Tanaka J, Imamura M, Asaka M. J Clin Microbiol; 2006 Dec 09; 44(12):4441-3. PubMed ID: 17035500 [Abstract] [Full Text] [Related]
7. [Comparative evaluation of effectiveness of traditional serologic and modified methods of herpes zoster laboratory diagnostics]. Kazanova AS, Lavrov VF, Kuzin SN, Ébralidze LK, Vedunova SL, Malyshev NA, Rusanova SA, Kuzina LE. Zh Mikrobiol Epidemiol Immunobiol; 2013 Dec 09; (2):83-90. PubMed ID: 23805677 [Abstract] [Full Text] [Related]
8. Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod. Harrer A, Wipfler P, Pilz G, Oppermann K, Haschke-Becher E, Afazel S, Kraus J, Trinka E, Sellner J. Int J Mol Sci; 2015 Sep 10; 16(9):21832-45. PubMed ID: 26378517 [Abstract] [Full Text] [Related]
9. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection. Schub D, Janssen E, Leyking S, Sester U, Assmann G, Hennes P, Smola S, Vogt T, Rohrer T, Sester M, Schmidt T. J Infect Dis; 2015 Feb 15; 211(4):600-12. PubMed ID: 25180236 [Abstract] [Full Text] [Related]
14. Subclinical reactivation of varicella zoster virus in all stages of HIV infection. Birlea M, Arendt G, Orhan E, Schmid DS, Bellini WJ, Schmidt C, Gilden D, Cohrs RJ. J Neurol Sci; 2011 May 15; 304(1-2):22-4. PubMed ID: 21419427 [Abstract] [Full Text] [Related]
19. Seroprevalence of varicella-zoster virus in Korea. Choi WS, Noh JY, Huh JY, Jo YM, Lee J, Song JY, Kim WJ, Cheong HJ. J Med Virol; 2010 Dec 15; 82(12):2123-6. PubMed ID: 20981803 [Abstract] [Full Text] [Related]